Sponsor study identifier
Secondary identifiers
observational
7
1 country
1
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2009
Actual (reported)Study Completion
June 2010
Actual (reported)Serotonin re-uptake inhibitors, such as sertraline, are the medication of choice in post-traumatic stress disorder. However, it takes several weeks before they ameliorate symptoms. Therefore, we will add ziprasidone (vs. placebo) medication during the first four weeks of sertraline in order to find out if this strategy accelerates symptomatic relief.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
November 2, 2005
Actual (reported)November 3, 2005
Actual (reported)August 2009
Actual (reported)June 2010
Actual (reported)Post-Traumatic Diagnostic Scale (PDS)
56 days
Beck Depression Inventory (BDI)
56 days
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
ziprasidone, sertraline
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordPTSD patients
UKE, Dept. of Psychiatry and Psychotherapy
Hamburg, 2ß246, Germany
Kellner M, Muhtz C, Wiedemann K. Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial? J Clin Psychopharmacol. 2010 Aug;30(4):471-3. doi: 10.1097/JCP.0b013e3181e79600. No abstract available.
Michael B Kellner, MD, PhD
UKE, Dep. of Pschiatry and Psychotherapy, Hamburg, Germany
7 participants (actual enrollment reported by the registry).
First Submitted
November 2, 2005
First Posted
November 3, 2005
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Immunological Changes Through Narrative Treatment of Post-Traumatic Stress Disorder (PTSD) in Torture Victims
Contact the study team to confirm eligibility.
Primary Completion
August 2009
Actual (reported)Study Completion
June 2010
Actual (reported)Last Updated
February 25, 2020
Record last verified: 2020-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: